Monopar Therapeutics - Common Stock, par value $0.001 per share (MNPR)
CUSIP: 61023L207
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 6,743,758
- Total 13F shares
- 4,336,026
- Share change
- +1,159,180
- Total reported value
- $354,298,233
- Price per share
- $81.67
- Number of holders
- 55
- Value change
- +$99,764,618
- Number of buys
- 32
- Number of sells
- 18
Quarterly Holders Quick Answers
What is CUSIP 61023L207?
CUSIP 61023L207 identifies MNPR - Monopar Therapeutics - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 61023L207:
Top shareholders of MNPR - Monopar Therapeutics - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC |
13D/G
13F
|
Company |
20%
|
1,287,368
|
$105,138,701 | +$9,391,992 | 30 Sep 2025 | |
| Adage Capital Management, L.P. |
13D/G
|
— |
9.9%
|
599,195
|
$26,706,121 | $0 | 31 Dec 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
8.9%
|
599,195
|
$21,439,197 | — | 30 Jun 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
7.6%
|
511,207
|
$18,290,986 | — | 30 Jun 2025 | |
| Tactic Pharma LLC |
3/4/5
|
10%+ Owner |
4%
|
272,026
|
$17,303,519 | -$34,999,957 | 24 Sep 2025 | |
| BlackRock, Inc. |
13F
|
Company |
3%
|
205,169
|
$7,340,947 | — | 30 Jun 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.5%
|
104,019
|
$3,721,800 | — | 30 Jun 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
1.5%
|
100,974
|
$3,612,850 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
96,919
|
$3,468,356 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.3%
|
86,489
|
$3,094,576 | — | 30 Jun 2025 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
1%
|
67,500
|
$2,415,150 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.62%
|
41,826
|
$1,496,534 | — | 30 Jun 2025 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
0.51%
|
34,537
|
$1,235,734 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.47%
|
31,813
|
$1,138,269 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.32%
|
21,873
|
$782,616 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.22%
|
14,789
|
$529,150 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.2%
|
13,249
|
$474,049 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.13%
|
8,948
|
$320,153 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.12%
|
8,356
|
$298,978 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.12%
|
7,932
|
$283,807 | — | 30 Jun 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.11%
|
7,285
|
$260,657 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.09%
|
6,232
|
$222,981 | — | 30 Jun 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.09%
|
5,850
|
$209,305 | — | 30 Jun 2025 | |
| GERBER, LLC |
13F
|
Company |
0.08%
|
5,601
|
$200,404 | — | 30 Jun 2025 | |
| Michael J. Brown |
3/4/5
|
Director |
—
class O/S missing
|
402,530
|
$136,941 | — | 31 Dec 2023 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.05%
|
3,385
|
$121,115 | — | 30 Jun 2025 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.04%
|
2,900
|
$103,762 | — | 30 Jun 2025 | |
| Andrew Paul Mazar |
3/4/5
|
Chief Scientific Officer, Director |
—
mixed-class rows
|
277,584
mixed-class rows
|
$94,434 | — | 31 Mar 2022 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.04%
|
2,538
|
$90,809 | — | 30 Jun 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.03%
|
2,301
|
$82,330 | — | 30 Jun 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.03%
|
2,222
|
$79,503 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
2,109
|
$75,460 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.03%
|
1,921
|
$68,733 | — | 30 Jun 2025 | |
| AlphaQuest LLC |
13F
|
Company |
0.03%
|
1,784
|
$63,832 | — | 30 Jun 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.02%
|
1,443
|
$51,631 | — | 30 Jun 2025 | |
| Police & Firemen's Retirement System of New Jersey |
13F
|
Company |
0.01%
|
964
|
$34,492 | — | 30 Jun 2025 | |
| NewEdge Advisors, LLC |
13F
|
Company |
0.01%
|
600
|
$21,468 | — | 30 Jun 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.01%
|
453
|
$16,041 | — | 30 Jun 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.01%
|
431
|
$15,421 | — | 30 Jun 2025 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0.01%
|
415
|
$14,849 | — | 30 Jun 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.01%
|
347
|
$12,416 | — | 30 Jun 2025 | |
| Karthik Radhakrishnan |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
126,550
mixed-class rows
|
$10,447 | — | 28 Oct 2024 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0%
|
254
|
$9,088 | — | 30 Jun 2025 | |
| AMALGAMATED BANK |
13F
|
Company |
0%
|
139
|
$5,000 | — | 30 Jun 2025 | |
| Allworth Financial LP |
13F
|
Company |
0%
|
100
|
$3,578 | — | 30 Jun 2025 | |
| FMR LLC |
13F
|
Company |
0%
|
31
|
$1,109 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
19
|
$1,000 | — | 30 Jun 2025 | |
| Sterling Capital Management LLC |
13F
|
Company |
0%
|
10
|
$358 | — | 30 Jun 2025 | |
| Jose Octavio Pinto Costa Filho |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
91,500
|
— | — | 12 Jul 2021 |
Institutional Holders of Monopar Therapeutics - Common Stock, par value $0.001 per share (MNPR) as of Q3 2025
As of 30 Sep 2025,
Monopar Therapeutics - Common Stock, par value $0.001 per share (MNPR) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,336,026 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, ADAGE CAPITAL PARTNERS GP, L.L.C., RA CAPITAL MANAGEMENT, L.P., WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock, Inc., DEERFIELD MANAGEMENT COMPANY, L.P., Saturn V Capital Management LP, TCG Crossover Management, LLC, and ADAR1 Capital Management, LLC.
This page lists
55
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
43
Q3 2025 holders
55
Holder diff
12
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.